Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In situ sol-gel-sol transformation formed by sodium alginate realizes folic acid-modified chitosan nanoparticles to deliver hops β-acids for colorectal cancer therapy.

Journal of nanobiotechnology·2026
Same author

[Genetic disease diagnosis and treatment in Shanghai: Survey and countermeasures for clinical genetics specialist training].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics·2026
Same author

GBA1 F213I mutation increases the expression of LCN2 promoting neurodegeneration.

Cell death and differentiation·2026
Same author

FOXI3 establishes the ectodermal niche in pharyngeal arches for cranial neural crest cells and their lineages.

Bone research·2026
Same author

Retraction Note: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression.

Nature communications·2025
Same author

pH-responsive magnetic Fe<sub>3</sub>O<sub>4</sub> modified chitosan nanoparticles loaded with β-acids to improve colorectal cancer treatment.

Materials today. Bio·2025

Related Experiment Video

Updated: Apr 12, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.9K

Thymic derived iPs cells can be differentiated into cardiomyocytes.

Jian Li, Yin-yin Cao, Xiao-jing Ma

  • 1Children's Hospital of Fudan University, Shanghai 201102, China.

Frontiers in Bioscience (Landmark Edition)
|May 12, 2015
PubMed
Summary

Induced pluripotent stem (iPS) cells were generated from a patient with ventricular septal defect (VSD). These VSD-iPS cells can differentiate into cardiomyocytes, offering a new model for studying congenital heart defects.

More Related Videos

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

22.3K
Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation
11:53

Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation

Published on: March 18, 2015

19.8K

Related Experiment Videos

Last Updated: Apr 12, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.9K
Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

22.3K
Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation
11:53

Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation

Published on: March 18, 2015

19.8K

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Developmental Biology

Background:

  • Ventricular septal defect (VSD) is a common congenital heart malformation with diverse etiologies.
  • Understanding VSD pathogenesis requires effective cellular models for patient-specific studies.

Purpose of the Study:

  • To generate induced pluripotent stem (iPS) cells from a VSD patient.
  • To assess the potential of VSD-iPS cells to differentiate into cardiomyocytes.
  • To establish a novel in vitro model for VSD research.

Main Methods:

  • Reprogramming of thymic epithelial cells (TECs) from a VSD patient into iPS cells using OCT4, SOX2, NANOG, and LIN28 factors via lentiviral vectors.
  • Verification of pluripotency and self-renewal through in vitro marker expression and in vivo teratoma formation.
  • Induction of cardiomyocyte differentiation from VSD-iPS cells.

Main Results:

  • Successful generation of VSD-iPS cell lines with confirmed pluripotency and self-renewal capabilities.
  • Demonstrated potential of VSD-iPS cells to differentiate into functional cardiomyocytes.
  • Established a patient-derived iPS cell model for VSD.

Conclusions:

  • Patient-derived VSD-iPS cells represent a valuable tool for investigating VSD pathophysiology.
  • This model system aids in identifying the underlying causes of VSD.
  • Cardiomyocyte differentiation from VSD-iPS cells opens avenues for regenerative medicine approaches in congenital heart disease.